01 julio 2016

JACC. Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement

James B. Hermiller, Jr., MDa; Steven J. Yakubov, MDb; Michael J. Reardon, MDc; G. Michael Deeb, MDd; David H. Adams, MDe; Jonathan Afilalo, MD, MScf; Jian Huang, MDg; Jeffrey J. Popma, MDh

Background: Few studies have examined the impact of novel indices of comorbidity, frailty, and disability on outcomes after transcatheter aortic valve replacement (TAVR).

01 julio 2016

JACC. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease. A Multicenter Observational Study

John D. Puskas, MDa,b; Michael E. Halkos, MDc; Joseph J. DeRose, MDd; Emilia Bagiella, PhDe; Marissa A. Miller, DMV, MPHf; Jessica Overbey, MSe; Johannes Bonatti, MDg; V.S. Srinivas, MDd; Mark Vesely, MDh; Francis Sutter, MDi; Janine Lynch, MPHj; Katherine Kirkwood, MSe; Timothy A. Shapiro, MDi; Konstantinos D. Boudoulas, MDj; Juan Crestanello, MDj; Thomas Gehrig, MDk; Peter Smith, MDk; Michael Ragosta, MDl; Steven J. Hoff, MDm; David Zhao, MDn; Annetine C. Gelijns, PhDe; Wilson Y. Szeto, MDo; Giora Weisz, MDp; Michael Argenziano, MDp; Thomas Vassiliades, MDc,q; Henry Liberman, MDc; William Matthai, MDo; Deborah D. Ascheim, MDa,e

Background: Hybrid coronary revascularization (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior descending artery with percutaneous coronary intervention (PCI) of non–left anterior descending vessels. HCR is increasingly used to treat multivessel coronary artery disease that includes stenoses in the proximal left anterior descending artery and at least 1 other vessel, but its effectiveness has not been rigorously evaluated.

01 julio 2016

JACC. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease

Mineok Chang, MDa; Jung-Min Ahn, MDa; Cheol Whan Lee, MDa; Rafael Cavalcante, MDb; Yohei Sotomi, MDc; Yoshinobu Onuma, MDb; Erhan Tenekecioglu, MDb; Minkyu Han, PhDd; Duk-Woo Park, MDa; Soo-Jin Kang, MDa; Seung-Whan Lee, MDa; Young-Hak Kim, MDa; Seong-Wook Park, MD, PhDa; Patrick W. Serruys, MD, PhDb,e; Seung-Jung Park, MD, PhDa

Background: In diabetic patients with multivessel coronary artery disease (CAD), the survival difference between coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) favors CABG. However, there are few data on the mortality difference between the 2 strategies in nondiabetic patients.

01 junio 2016

JACC. Treatment of Chronic Functional Mitral Valve Regurgitation With a Percutaneous Annuloplasty System

Georg Nickenig, MDa; Robert Schueler, MDa; Antonio Dager, MDb; Pedro Martinez Clark, MDb; Alexandre Abizaid, MDc; Tomasz Siminiak, MDd; Pawel Buszman, MDe; Marcin Demkow, MDf; Adrian Ebner, MDg; Federico M. Asch, MDh; Christoph Hammerstingl, MDa

Background: Current surgical and medical treatment options for functional mitral regurgitation (FMR) are limited and additional interventional approaches are required.

01 junio 2016

JACC. First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Paul Sorajja, MD; Wesley A. Pedersen, MD; Richard Bae, MD; John R. Lesser, MD; Desmond Jay, MD; David Lin, MD; Kevin Harris, MD; Barry J. Maron, MD

Background: Few therapeutic options exist for patients with severe heart failure due to obstructive hypertrophic cardiomyopathy (HCM) who are at unacceptable surgical risk. We hypothesized that percutaneous plication of the mitral valve could reduce left ventricular outflow tract (LVOT) obstruction and associated mitral regurgitation, thereby leading to amelioration of heart failure symptoms.

01 junio 2016

JACC. Endovascular Repair Compared With Medical Management of Patients With Uncomplicated Type B Acute Aortic Dissection

Yong-Lin Qin, MDa; Feng Wang, MDb; Tian-Xiao Li, MDc; Wei Ding, MDa; Gang Deng, MDa; Bo Xie, MDa; Gao-Jun Teng, MDa

Background: Thoracic endovascular aortic repair (TEVAR) has been used in patients with uncomplicated type B acute aortic dissection (B-AAD) to reduce late morbidity and mortality. The outcomes of comparisons between TEVAR and best medical treatment (BMT) on patients with uncomplicated type B-AAD are inconsistent in the published reports.

01 junio 2016

JACC. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention

Vincent Roolvink, MDa; Borja Ibáñez, MD, PhDb,c; Jan Paul Ottervanger, MD, PhDa; Gonzalo Pizarro, MDb,d; Niels van Royen, MD, PhDe; Alonso Mateos, MDf; Jan-Henk E. Dambrink, MD, PhDa; Noemi Escalera, BPTb; Erik Lipsic, MD, PhDg; Agustín Albarran, MD, PhDh,i; Antonio Fernández-Ortiz, MD, PhDh,j; Francisco Fernández-Avilés, MD, PhDh,k; Javier Goicolea, MD, PhDh,l; Javier Botas, MD, PhDh,m; Wouter Remkes, MDa; Victoria Hernandez-Jaras, PharmDf; Elvin Kedhi, MD, PhDa; José L. Zamorano, MD, PhDh,n; Felipe Navarro, MD, PhDc,h; Fernando Alfonso, MD, PhDh,o; Alberto García-Lledó, MD, PhDh,p; Joaquin Alonso, MD, PhDh,q; Maarten van Leeuwen, MDe; Robin Nijveldt, MD, PhDe; Sonja Postma, PhDr; Evelien Kolkman, MScr; Marcel Gosselink, MD, PhDa; Bart de Smet, MD, PhDs; Saman Rasoul, MD, PhDt; Jan J. Piek, MD, PhDu; Valentin Fuster, MD, PhDb,v; Arnoud W.J. van ´t Hof, MD, PhDa

Background: The impact of intravenous (IV) beta-blockers before primary percutaneous coronary intervention (PPCI) on infarct size and clinical outcomes is not well established.

01 junio 2016

JACC. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement

G. Michael Deeb, MDa; Michael J. Reardon, MDb; Stan Chetcuti, MDa; Himanshu J. Patel, MDa; P. Michael Grossman, MDa; Steven J. Yakubov, MDc; Neal S. Kleiman, MDb; Joseph S. Coselli, MDd; Thomas G. Gleason, MDe; Joon Sup Lee, MDe; James B. Hermiller, Jr., MDf; John Heiser, MDg; William Merhi, MDg; George L. Zorn, III, MDh; Peter Tadros, MDh; Newell Robinson, MDi; George Petrossian, MDi; G. Chad Hughes, MDj; J. Kevin Harrison, MDj; Brijeshwar Maini, MDk; Mubashir Mumtaz, MDk; John Conte, MDl; Jon Resar, MDl; Vicken Aharonian, MDm; Thomas Pfeffer, MDm; Jae K. Oh, MDn; Hongyan Qiao, PhDo; David H. Adams, MDp; Jeffrey J. Popma, MDq

Background: In patients with severe aortic stenosis at increased risk for surgery, self-expanding transcatheter aortic valve replacement (TAVR) is associated with improved 2-year survival compared with surgery.

17 abril 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Cardiac Catheterization. Relationship Between Femoral Vascular Closure Devices and Short-Term Mortality From 271 845 Percutaneous Coronary Intervention Procedures Performed in the United Kingdom Between 2006 and 2011. A Propensity Score–Corrected Analysis From the British Cardiovascular Intervention Society

Vasim Farooq, MBChB, MRCP, PhD, Dick Goedhart, PhD, Peter Ludman, MA, MD, FRCP, Mark A. de Belder, MA, MD, FRCP, Alun Harcombe, MbChB, MD, FRCP and Magdi El-Omar, BSc, MBBS, MD, MRCP; on behalf of the British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research

Background: The impact of vascular closure devices (VCDs) via the femoral arterial access site on short-term mortality in patients undergoing percutaneous coronary intervention is currently unknown.

29 abril 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Congenital Heart Disease. Balloon Dilatation and Stenting for Aortic Coarctation. A Systematic Review and Meta-Analysis

Maximilian Salcher, MSc, Huseyin Naci, PhD, Tyler J. Law, MD, Titus Kuehne, MD, Stephan Schubert, MD, Marcus Kelm, MD, on behalf of Cardioproof Consortium*

Background: There is no systematic assessment of available evidence on effectiveness and comparative effectiveness of balloon dilatation and stenting for aortic coarctation.

27 abril 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Coronary Interventions. Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated With Percutaneous Coronary Intervention

Grant W. Reed, MD, Ahmad Masri, MD, Brian P. Griffin, MD, Samir R. Kapadia, MD, Stephen G. Ellis, MD and Milind Y. Desai, MD

Background: The incidence and predictors of long-term mortality after percutaneous coronary intervention (PCI) for radiation-associated coronary artery disease are unknown.

27 abril 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Coronary Interventions. Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry

Dimitri Karmpaliotis, MD, Aris Karatasakis, MD, Khaldoon Alaswad, MD, Farouc A. Jaffer, MD, PhD, Robert W. Yeh, MD, R. Michael Wyman, MD, William L. Lombardi, MD, J. Aaron Grantham, MD, David E. Kandzari, MD, Nicholas J. Lembo, MD, Anthony Doing, MD, Mitul Patel, MD, John N. Bahadorani, MD, Jeffrey W. Moses, MD, Ajay J. Kirtane, MD, Manish Parikh, MD, Ziad A. Ali, MD, Sanjog Kalra, MD, MSc, Phuong-Khanh J. Nguyen-Trong, MD, Barbara A. Danek, MD, Judit Karacsonyi, MD, Bavana V. Rangan, BDS, MPH, Michele K. Roesle, RN, BSN, Craig A. Thompson, MD, MMSc, Subhash Banerjee, MD and Emmanouil S. Brilakis, MD, PhD

Background: We sought to examine the efficacy and safety of chronic total occlusion percutaneous coronary intervention using the retrograde approach.

27 abril 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Coronary Interventions. Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction. Insights From the HMO Research Network-Stent Registry

Javier A. Valle, MD, MSc, Susan Shetterly, MS, Thomas M. Maddox, MD, MSc, P. Michael Ho, MD, PhD, Steven M. Bradley, MD, MPH, Amneet Sandhu, MD, David Magid, MD, MPH and Thomas T. Tsai, MD, MSc

Background: Bleeding after hospital discharge from percutaneous coronary intervention (PCI) is associated with increased risk of subsequent myocardial infarction (MI) and death; however, the timing of adverse events after these bleeding events is poorly understood. Defining this relationship may help clinicians identify critical periods when patients are at highest risk.

14 abril 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Peripheral Vascular Disease. Helical Centerline Stent Improves Patency. Two-Year Results From the Randomized Mimics Trial

Thomas Zeller, MD, Peter A. Gaines, MD, Gary M. Ansel, MD and Colin G. Caro, MD

Background: Reintervention in the femoropopliteal artery is frequent and a major driver of cost-effectiveness. High wall shear generated by swirling blood flow is associated with reduced occurrence of atherosclerosis and restenosis. This trial investigated the clinical and hemodynamic outcomes of the BioMimics 3D self-expanding tubular nitinol stent with helical centerline geometry compared with a straight stent in the femoropopliteal artery.

16 mayo 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Structural Heart Disease. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery. A Study of Echocardiographic Change and Risk Prediction

Stephen H. Little, MD, Jae K. Oh, MD, Linda Gillam, MD, MPH, Partho P. Sengupta, MD, David A. Orsinelli, MD, João L. Cavalcante, MD, James D. Chang, MD, David H. Adams, MD, George L. Zorn III, MD, Amy W. Pollak, MD, Sahar S. Abdelmoneim, MD, Michael J. Reardon, MD, Hongyan Qiao, PhD and Jeffrey J. Popma, MD

Background: The CoreValve US High-Risk Clinical Study compared clinical outcomes and serial echocardiographic findings in patients with severe aortic valve stenosis after transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis or surgical aortic valve replacement (SAVR).